Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938884 · ClinicalTrials.gov registry record · NA
Hidrate Me Smart Water Bottle Use in Patient With Nephrolithiasis
A NA study of Nephrolithiasis and Low Urine Volume, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 4
- Study locations
NCT02938884: Completed NA study of Nephrolithiasis and Low Urine Volume, sponsored by University of Minnesota.
NCT02938884 is a NA study of Nephrolithiasis and Low Urine Volume that has completed, run by University of Minnesota. The registered enrollment target is 85 participants, below the 119-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (29% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02938884, a NA study of Nephrolithiasis and Low Urine Volume, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this study would be to determine whether utilization of this technology improves adherence to recommended increases in hydration for stone forming patients with low urine volume relative to standard techniques such as education and reading materials. We hypothesize that the addition and utilization of the smart water bottle to standard recommendations will lead to measurable increases 24 hour urine output for affected patients.
Conditions Studied
Interventions
- DEVICE HidrateSpark Water Bottle
Study Locations (4)
Arizona
- Mayo Clinic Scottsdale - Scottsdale
Illinois
- University of Chicago - Chicago
Indiana
- Indiana University - Bloomington
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2016-12-05 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
What the finished NCT02938884 record still lists
NCT02938884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 119-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (29% lower).
The record links to 2 conditions, with Nephrolithiasis appearing as the primary indexed condition, and to 1 intervention - of which HidrateSpark Water Bottle is the first listed.
NCT02938884 reports a single indexed study location in Arizona, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT02938884 about?
NCT02938884 is a clinical study titled "Hidrate Me Smart Water Bottle Use in Patient With Nephrolithiasis". The primary objective of this study would be to determine whether utilization of this technology improves adherence to recommended increases in hydration for stone forming patients with low urine volume relative to standard techniques such as education and reading materials. We hypothesize that the ...
What is the current status of trial NCT02938884?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2016-12-05. Estimated completion is 2021-01-31.
What conditions does trial NCT02938884 study?
This clinical trial studies the following conditions: Nephrolithiasis, Low Urine Volume.
What interventions are being tested in trial NCT02938884?
The interventions under investigation include: HidrateSpark Water Bottle (DEVICE).
Who is sponsoring clinical trial NCT02938884?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02938884 being conducted?
This trial has 4 study locations across Arizona, Illinois, Indiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02938884's enrollment target sits among peer trials
85 9th of 16 higher than 8 of 16 other Nephrolithiasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nephrolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI